Irreversible electroporation and electrochemotherapy in oncology: State of the art

JP Tasu, D Tougeron, MP Rols - Diagnostic and Interventional Imaging, 2022 - Elsevier
Thermal tumor ablation techniques including radiofrequency, microwave, LASER, high-
intensity focused ultrasound and cryoablation are routinely used to treated liver, kidney …

[HTML][HTML] Advances in Image-Guided Ablation Therapies for Solid Tumors

WA Campbell IV, MS Makary - Cancers, 2024 - mdpi.com
Simple Summary Image-guided solid tumor ablation therapy is an expanding practice
designed to effectively target and eradicate malignant tissue through noninvasive or …

Prostate Biopsy in Men with an Elevated PSA Level—Reducing Overdiagnosis

PF Pinsky - New England Journal of Medicine, 2024 - Mass Medical Soc
Research into magnetic resonance imaging (MRI) for prostate cancer screening and
diagnosis has been ongoing for more than a decade. Initially, MRI was thought to be …

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs

MM Kouspou, JE Fong, N Brew, STF Hsiao… - Nature Reviews …, 2020 - nature.com
Prostate cancer is a heterogeneous cancer with widely varying levels of morbidity and
mortality. Approaches to prostate cancer screening, diagnosis, surveillance, treatment and …

[HTML][HTML] Multiparametric MRI in active surveillance of prostate cancer: an overview and a practical approach

CH Lee, TW Tan, CH Tan - Korean Journal of Radiology, 2021 - ncbi.nlm.nih.gov
MRI has become important for the detection of prostate cancer. MRI-guided biopsy is
superior to conventional systematic biopsy in patients suspected with prostate cancer. MRI is …

Active surveillance strategies for low-grade prostate cancer: comparative benefits and cost-effectiveness

SK Kang, RD Mali, V Prabhu, BS Ferket, S Loeb - Radiology, 2021 - pubs.rsna.org
Background Active surveillance (AS) is the recommended treatment option for low-risk
prostate cancer (PC). Surveillance varies in MRI, frequency of follow-up, and the Prostate …

Projected outcomes of reduced-biopsy management of grade group 1 prostate cancer: implications for relabeling

Y Zhao, R Gulati, Z Yang, L Newcomb… - JNCI: Journal of the …, 2024 - academic.oup.com
Background Implications of relabeling grade group (GG) 1 prostate cancer as non-cancer
will depend on the recommended active surveillance (AS) strategy. Whether relabeling …

[HTML][HTML] Prostate cancer patients under active surveillance with a suspicious magnetic resonance imaging finding are at increased risk of needing treatment: results of …

J Olivier, W Li, D Nieboer, J Helleman, M Roobol… - European Urology Open …, 2022 - Elsevier
Background The inclusion criterion for active surveillance (AS) is low-or intermediate-risk
prostate cancer. The predictive value of the presence of a suspicious lesion at magnetic …

Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance

II de Vos, D Nieboer, M Frydenberg… - JAMA Network …, 2025 - jamanetwork.com
Importance Active surveillance (AS) for patients with prostate cancer (PC) often includes
fixed repeat prostate biopsies that do not account for the varying risk of reclassification to …

De-escalation of monitoring in active surveillance for prostate cancer: results from the GAP3 consortium

Y Tohi, JM Sahrmann, J Arbet, T Kato, LS Lee… - European Urology …, 2024 - Elsevier
Background and objective There is no consensus on de-escalation of monitoring during
active surveillance (AS) for prostate cancer (PCa). Our objective was to determine clinical …